As more patients seek these medications, prior authorization has become an increasingly common step in the approval process
Your body is not broken, it needs support to heal the way it's designed to
Clinical Studies or Real-World Outcomes Several clinical trials support the efficacy of OZEMPIC in controlling blood sugar levels and reducing cardiovascular risks: Monotherapy Trial : Patients treated with OZEMPIC 1 mg saw an average HbA1c reduction of 1.6% after 30 weeks, compared to 0.1% for placebo
Standard IGF-1 LR3 Dosage Protocols The optimal dose depends on your experience level, body weight, and goals
Originally developed to manage type 2 diabetes, both medications are now widely used for weight loss due to their ability to reduce appetite, regulate insulin, and support long-term fat loss
doi: 10.2337/diabetes.53.3.654 21 HansenLDeaconCFOrskovCHolstJJ